Cadila Healthcare informs about press release

18 Sep 2021 Evaluate

Cadila Healthcare has informed that it enclosed Press release dated September 18, 2021 titled 'Zydus Cadila receives final approval from USFDA for Vortioxetine Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

953.50 20.10 (2.15%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.